|

MK-1045 Clinical Trials

3 actively recruiting trials

Also known as: CN201

Pipeline

Phase 1: 2Phase 1/2: 1

Top Sponsors

  • MSD R&D (China) Co., Ltd.2
  • Merck Sharp & Dohme LLC1

Indications

  • Cancer2
  • Systemic Lupus Erythematosus1
  • Lupus1
  • Arthritis1
  • Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma1

Other3 trials

A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)
Phase 1/2
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Phase 1
A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.